现在的位置: 首页时讯速递, 进展交流>正文
[JAMA发表论文]:急性肾损伤住院患者的早期个体化治疗推荐意见
2025年01月02日 时讯速递, 进展交流 [JAMA发表论文]:急性肾损伤住院患者的早期个体化治疗推荐意见已关闭评论

Original Investigation 

October 25, 2024

Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury: A Randomized Clinical Trial

Abinet M. Aklilu, Steven Menez, Megan L. Baker, et al

JAMA. 2024;332(24):2081-2090. doi:10.1001/jama.2024.22718

Key Points

Question  Among hospitalized patients with acute kidney injury, do diagnostic and therapeutic recommendations sent by a kidney action team through the electronic health record prevent the primary outcome of worsening kidney injury stage, dialysis, or mortality?

Findings  In this randomized clinical trial involving 4003 patients hospitalized with acute kidney injury, the intervention did not reduce the primary outcome compared with usual care (19.8% for intervention vs 18.4% for usual care.

Meaning  These results do not support a kidney action team to prevent worsening kidney injury, dialysis, or death among patients hospitalized with acute kidney injury.

Abstract

Importance  Acute kidney injury (AKI) is a common complication during hospitalization and is associated with adverse outcomes.

Objective  To evaluate whether diagnostic and therapeutic recommendations sent by a kidney action team through the electronic health record improve outcomes among patients hospitalized with AKI compared with usual care.

Design, Setting, and Participants  Randomized clinical trial conducted at 7 hospitals in 2 health systems: in New Haven, Bridgeport, New London, and Waterbury, Connecticut, and Westerly, Rhode Island; and in Baltimore, Maryland. Hospitalized patients with AKI were randomized between October 29, 2021, and February 8, 2024. Final follow-up occurred February 22, 2024.

Intervention  An alert about AKI was sent to the kidney action team, consisting of a study physician and study pharmacist, which sent personalized recommendations through the electronic health record in 5 major categories (diagnostic testing, volume, potassium, acid base, and medications) within 1 hour of AKI detection. The note was immediately visible to anyone with access to the electronic health record. Randomization to the intervention or usual care occurred after the recommendations were generated, but the note was only delivered to clinicians of patients randomized to the intervention group.

Main Outcomes and Measures  The primary outcome was a composite outcome consisting of AKI progression to a higher stage of AKI, dialysis, or mortality occurring while the patient remained hospitalized and within 14 days from randomization.

Results  Of the 4003 patients randomized (median age, 72 years [IQR, 61-81 years), 1874 (47%) were female and 931 (23%) were Black patients. The kidney action team made 14 539 recommendations, with a median of 3 (IQR, 2-5) per patient. The primary outcome occurred in 19.8% of the intervention group and in 18.4% in the usual care group (difference, 1.4%, 95% CI, −1.1% to 3.8,% P = .28). Of 6 secondary outcomes, only 1 secondary outcome, rates of recommendation implementation, significantly differed between the 2 groups: 2459 of 7270 recommendations (33.8%) were implemented in the intervention group and 1766 of 7269 undelivered recommendations (24.3%) were implemented in the usual care group within 24 hours (difference, 9.5%; 95% CI, 8.1% to 11.0%).

Conclusions and Relevance  Among patients hospitalized with AKI, recommendations from a kidney action team did not significantly reduce the composite outcome of worsening AKI stage, dialysis, or mortality, despite a higher rate of recommendation implementation in the intervention group than in the usual care group.

Trial Registration  ClinicalTrials.gov Identifier: NCT04040296

抱歉!评论已关闭.

×
腾讯微博